Wilking N, Appelgren L E, Carlström K, Pousette A, Theve N O
Acta Pharmacol Toxicol (Copenh). 1982 Mar;50(3):161-8. doi: 10.1111/j.1600-0773.1982.tb00958.x.
The distribution and metabolism of 14C-tamoxifen (a non-steroidal triaryl ethylene anti-oestrogen) have been investigated in ovarieectomized mice. The autoradiograms showed accumulation of radioactivity in the liver and the bile as an indication of an excretory pathway, but a rapid and high accumulation was also seen in the lung and the adrenals, organs normally not considered as target organs for tamoxifen. The liver and sebaceous glands could be detected on the autoradiograms up to fourteen days after a single intravenous dose. However, in most organs the amount of retained radioactivity was very low after 24 hours. By using the autoradiograms as a guideline a metabolic study was performed. High concentrations of unmetabolized tamoxifen was detected in the lung and the adrenals as well as in the pancreas. Relatively high amounts of a compound tentatively identified as 4-hydroxy-tamoxifen were present in the pancreas and the liver and there were also indications for the presence of N-desmethyl-tamoxifen in these tissues. These metabolites are considered to possess anti-oestrogenic activity.
已在去卵巢小鼠中研究了14C-他莫昔芬(一种非甾体三芳基乙烯抗雌激素)的分布和代谢。放射自显影片显示肝脏和胆汁中有放射性积累,这表明存在排泄途径,但在肺和肾上腺中也观察到放射性的快速和高度积累,而这些器官通常不被认为是他莫昔芬的靶器官。单次静脉注射后长达14天,在放射自显影片上仍可检测到肝脏和皮脂腺。然而,在大多数器官中,24小时后保留的放射性量非常低。以放射自显影片为指导进行了一项代谢研究。在肺、肾上腺以及胰腺中检测到高浓度的未代谢他莫昔芬。在胰腺和肝脏中存在相对大量的一种暂定为4-羟基他莫昔芬的化合物,并且在这些组织中也有N-去甲基他莫昔芬存在的迹象。这些代谢物被认为具有抗雌激素活性。